ONCY
ONCY
NASDAQ · Biotechnology

Oncolytics Biotech Inc

$0.83
+0.03 (+3.24%)
As of Mar 31, 3:11 PM ET ·
Financial Highlights (FY 2025)
Revenue
14.90M
Net Income
2.54M
Gross Margin
46.5%
Profit Margin
17.0%
Rev Growth
-8.5%
D/E Ratio
0.17
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 46.5% 46.5% 46.5%
Operating Margin 28.4% 26.0% 23.2%
Profit Margin 17.0% 21.6% 18.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 14.90M 15.53M 15.53M
Gross Profit 6.92M 7.22M 7.22M
Operating Income 4.22M 4.04M 3.61M
Net Income 2.54M 3.35M 2.88M
Gross Margin 46.5% 46.5% 46.5%
Operating Margin 28.4% 26.0% 23.2%
Profit Margin 17.0% 21.6% 18.5%
Rev Growth -8.5% -1.6% +3.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.94M 12.63M 13.72M
Total Equity 86.70M 73.73M 86.18M
D/E Ratio 0.17 0.17 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.18M 5.39M 5.26M
Free Cash Flow 2.62M 3.23M 2.70M